A pharmacist-led medication assessment used to determine a more precise estimation of the prevalence of complementary and alternative medication (CAM) use among ambulatory senior adults with cancer

Journal of Geriatric Oncology

Volumn 6, Issue 5, 2015, Pages 411-417

  Nightingale, Ginah ^a   Hajjar, Emily ^a   Guo, Krystal ^b   Komura, Stephanie ^c   Urnoski, Eric ^d   Sendecki, Jocelyn ^e   Swartz, Kristine ^f   Chapman, Andrew ^f  

^a Jefferson School of Pharmacy   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^c ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL   (United States)

^d HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^e JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^f THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Cancer; Complementary medicine; Herbals; Medication use; Older adults; Polypharmacy

Indexed keywords

MINERAL; VITAMIN; ANTINEOPLASTIC AGENT;

ADULT; AGED; ALTERNATIVE MEDICINE; AMBULATORY CARE; ARTICLE; CAUCASIAN; COMORBIDITY; DIET SUPPLEMENTATION; DRUG USE; ELDERLY CARE; ELECTRONIC MEDICAL RECORD; FEMALE; GERIATRIC ASSESSMENT; HEALTH CARE UTILIZATION; HERBAL MEDICINE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICATION THERAPY MANAGEMENT; PHARMACIST; POLYPHARMACY; PREVALENCE; PRIORITY JOURNAL; SECONDARY ANALYSIS; SOLID TUMOR; URINARY TRACT DISEASE; VERY ELDERLY; VISUAL IMPAIRMENT; AGE; INAPPROPRIATE PRESCRIBING; MIDDLE AGED; NEOPLASMS; PRESCRIPTION; PREVENTION AND CONTROL; PROCEDURES; PROGRAM EVALUATION; RETROSPECTIVE STUDY; RISK FACTOR; STANDARDS; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMPLEMENTARY THERAPIES; DRUG PRESCRIPTIONS; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; MALE; MEDICATION RECONCILIATION; MIDDLE AGED; NEOPLASMS; PHARMACISTS; PREVALENCE; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84942824534     PISSN: 18794068     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgo.2015.07.003     Document Type: Article

References (31)

1. Nightingale G., Hajjar E., Swartz K., Sendecki J.A., Chapman A.E. A pharmacist-led medication assessment to identify prevalence and associations with potentially inappropriate medications (PIMs) among ambulatory senior adults with cancer. J Clin Oncol 2015, 10.1200/JCO.2014.60.3548.
2. Extermann M., Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol 2007, 25:1824-1831.
3. The NCCN Clinical Practice Guidelines in Oncology Senior Adult Oncology (version 2.2014) 2014, National Comprehensive Cancer Network, Inc., [accessed 2015 April 1].
4. Lees J., Chan A. Polypharmacy in elderly patients with cancer: clinical implications and management. Lancet Oncol 2011, 12:1249-1257.
5. Corcoran M.E. Polypharmacy in the older patient with cancer. Cancer Control 1997, 4:419-428.
6. Maggiore R.J., Gross C.P., Hurria A. Polypharmacy in older adults with cancer. Oncologist 2010, 15:507-522.
7. Maggiore R.J., Gross C.P., Togawa K., Tew W.P., Mohile S.G., Owusu C., et al. Use of complementary medications among older adults with cancer. Cancer 2012, 118:4815-4823.
8. Lichtman S.M., Boparai M.K. Geriatric medication management: evaluation of pharmacist interventions and potentially inappropriate medication (PIM) use in older (>65years) cancer patients. J Clin Oncol 2009, 27(Abstract 9507). [Available at: http://meeting.ascopubs.org/cgi/content/abstract/27/15S/9507].
9. Sokol K.C., Knudsen J.F., Li M.M. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management. J Clin Pharm Ther 2007, 32:169-175.
10. Wyatt G.K., Friedman L.L., Given C.W., Given B.A., Beckrow K.C. Complementary therapy use among older cancer patients. Cancer Pract 1999, 7:136-144.
11. Davis E.L., Oh B., Butow P.N., Mullan B.A., Clarke S. Cancer patient disclosure and patient-doctor communication of complementary and alternative medicine use: a systematic review. Oncologist 2012, 17:1475-1481.
12. Helyer L.K., Chin S., Chui B.K., et al. The use of complementary and alternative medicines among patients with locally advanced breast cancer-a descriptive study. BMC Cancer 2006, 6:39.
13. Holle L.M., Michaud L.B. Oncology pharmacists in health care delivery: vital members of the cancer care team. J Oncol Pract 2014, 10(3):e142-e145.
14. Kohn L.T. Institute of Medicine. Academic Health Centers: Leading Change in the 21st Century 2003, National Academy Press, Washington, DC.
15. Kohn L.T., Corrigan J.M., Donaldson M.S. To Err Is Human 2000, National Academy Press, Washington, DC.
16. Priority Areas for National Action. Transforming Health Care Quality 2003, The National Academies. Press, Washington, DC. K. Adams, J.M. Corrigan (Eds.).
17. National Cancer Institute National Cancer Institute Dictionary of Cancer Terms Available from:, [Accessed on January 3, 2014]. http://www.cancer.gov/dictionary/?CdrID%BC44384.
18. Stewart R.B. Polypharmacy in the Elderly: A Fait Accompli?. DICP 1990, 24:321-323.
19. Montamat S.C., Cusack B. Overcoming problems with polypharmacy and drug misuse in the elderly. Clin Geriatr Med 1992, 8:143-158.
20. Hajjar E.R., Cafiero A.C., Hanlon J.T. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007, 5:345-351.
21. Gallagher P., O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008, 37:673-679.
22. O'Mahony D., Gallagher P., Ryan C., Byrne S., Hamilton H., et al. STOPP & START criteria: a new approach to detecting potentially inappropriate prescribing in old age. Eur Geriatr Med 2010, 1:45-51.
23. Hamilton H., Gallagher P., et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011, 171(11):1013-1019.
24. National Committee for Quality Assurance HEDIS Technical Resources: Use of High-Risk Drugs in the Elderly (DAE) Available at, [[on-line], Accessed October 31, 2012]. http://www.ncqa.org/tabid/598/Default.aspx.
25. The American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012, 60:616-631.
26. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982, 5:649-655.
27. Balducci L. Extermann. Management of cancer in the older person: a practical approach. Oncologist 2000, 5:224-237.
28. Age-Related Eye Disease Study Research Group A randomized, placebo-controlled, clinical trial of high dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001, 119:1417-1436.
29. Krishnadev N., Meleth A.D., Chew E.Y. Nutritional supplements for age-related macular degeneration. Curr Opin Ophthalmol 2010, 21:184-189.
30. Chisholm-Burns M.A., Lee J.K., Spivey C., et al. U.S. pharmacists' effects as team members on patient care: systematic review and meta-analyses. Med Care 2010, 48:923-933.
31. Gillespie U., Alassaad A., Henrohn D., Garmo H., Hammarlund-Udenaes M., Toss H. Arch Intern Med 2009, 169:894-900.